In most cases, your doctor will start by prescribing oral medication. Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other ...

This occurs either because the pancreas doesn’t produce enough insulin (primarily type 1), the body’s cells develop resistance to insulin’s effects (primarily type 2), or a combination of ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising rates of type 2 diabetes and obesity. Medicare Part D faces financial ...

Among hospitalized adults with type ... 1 drug than those with an HbA1c of less than 6.5% (OR = 1.81; 95% CI, 1.28-2.6). Adults aged 40 to 60 years had higher odds for receiving a novel diabetes ...

The study, involving nearly 394,000 adults, demonstrates that certain diabetes medications may offer unexpected ... particularly for individuals managing type 2 diabetes. The progressive nature ...

For people with type 2 diabetes, those on glucose-lowering medications or insulin are at the most risk for low blood sugar. It is important to check with your doctor if you are having any symptoms ...

Medicare also covers GLP-1 receptor drugs, such as Ozempic, Munjaro, and Wegovy, for the treatment of type 2 diabetes. For more resources to help guide you through the complex world of medical ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive ...

Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...

More than 36 million Americans have type 2 diabetes ... GLP-1 medications can play an important role in helping people maintain this weight loss over the long term to treat diabetes and other ...

New research shows sotagliflozin is the only drug in its class to demonstrate these results. Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...